Pharma Mar, S.A.

Pharma Mar, S.A.verified

0RC6.L

Pharma Mar, S.A., a biopharmaceutical company, engages in the research, development, production, and commercialization of bio-active principles of marine origin for use in oncology in Spain, Italy, Germany, Ireland, rest of EU, the United States, and internationally. The company operates through three segments: Oncology, Diagnostics, and RNA interference. It develops and commercializes Yondelis for the treatment of soft tissue sarcomas and for ovarian cancer; Aplidin for treating multiple myeloma; and Zepzelca for treating patients with small cell lung cancer. The company also develops PM14 which is in phase II clinical trails for the treatment of solid tumors. In addition, it develops and m...[Read more]

Industry

Biotechnology

IPO Date

2015-11-05

Stock Exchange

LSE

Ticker

0RC6.L

The Enterprise Value as of November 2025 (TTM) for Pharma Mar, S.A. (0RC6.L) is 1.35B

According to Pharma Mar, S.A.’s latest financial reports and current stock price. The company's current Enterprise Value is 1.35B. This represents a change of 5.85% compared to the average of 1.27B of the last 4 quarters.

Pharma Mar, S.A. (0RC6.L) Historical Enterprise Value (quarterly & annually)

How has 0RC6.L Enterprise Value performed in the past?

The mean historical Enterprise Value of Pharma Mar, S.A. over the last ten years is 853.74M. The current 1.35B Enterprise Value has changed 15.71% with respect to the historical average. Over the past ten years (40 quarters), 0RC6.L's Enterprise Value was at its highest in in the September 2020 quarter at 1.93B. The Enterprise Value was at its lowest in in the December 2018 quarter at 311.80M.

Quarterly (TTM)
Annual

Average

853.74M

Median

798.85M

Minimum

311.51M

Maximum

1.39B

Pharma Mar, S.A. (0RC6.L) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Pharma Mar, S.A. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 175.54%

Maximum Annual Enterprise Value = 1.39B

Minimum Annual Increase = -51.56%

Minimum Annual Enterprise Value = 311.51M

Quarterly (TTM)
Annual
YearEnterprise ValueChange
20241.39B87.65%
2023739.38M-29.81%
20221.05B9.01%
2021966.34M-23.26%
20201.26B46.71%
2019858.32M175.54%
2018311.51M-51.56%
2017643.05M-5.30%
2016679.01M6.16%
2015639.63M-3.37%

Pharma Mar, S.A. (0RC6.L) Average Enterprise Value

How has 0RC6.L Enterprise Value performed in the past?

The current Enterprise Value of Pharma Mar, S.A. (0RC6.L) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

1.06B

5-year avg

1.08B

10-year avg

853.74M

Pharma Mar, S.A. (0RC6.L) Enterprise Value vs. Peers

How is 0RC6.L’s Enterprise Value compared to its peers?

Pharma Mar, S.A.’s Enterprise Value is less than Korian (8.64B), less than CompuGroup Medical SE & Co. KGaA (1.88B), greater than Medigene AG (-3756530.00), greater than PHAXIAM Therapeutics S.A. (3.80M), greater than Poxel S.A. (57.55M), greater than European Medical Solutions (14.01M), greater than Revenio Group Oyj (577.40M), greater than Safilo Group S.p.A. (790.84M), greater than Eckert & Ziegler Strahlen- und Medizintechnik AG (913.09M), greater than Biofrontera AG (7.50M),

Build a custom stock screener for Pharma Mar, S.A. (0RC6.L) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Pharma Mar, S.A. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Pharma Mar, S.A. (0RC6.L) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Pharma Mar, S.A. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is Pharma Mar, S.A.'s Enterprise Value?

What is the highest Enterprise Value for Pharma Mar, S.A. (0RC6.L)?

What is the 3-year average Enterprise Value for Pharma Mar, S.A. (0RC6.L)?

What is the 5-year average Enterprise Value for Pharma Mar, S.A. (0RC6.L)?

How does the current Enterprise Value for Pharma Mar, S.A. (0RC6.L) compare to its historical average?